Company,Trial Phase,Drug Name,Indication,Market Cap,IC50 (ÂµM),Status
Pfizer,Phase 3,PF-123456,Oncology,250B,0.45,Active
Moderna,Phase 2,mRNA-789,COVID-19,45B,,Recruiting
,Phase 1,ABC-101,Alzheimer's,12B,1.2,Active
Novartis,Phase 3,,Diabetes,180B,0.08,Completed
BioNTech,,BNT-222,Cancer,35B,0.92,Planning
Roche,Phase 2,RO-5555,Inflammation,,0.15,Active
GSK,Phase 3,GSK-999,Respiratory,90B,,Recruiting
Merck,Phase 1,MRK-444,,200B,2.5,